Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Operating Leases (2019 - 2025)

Historic Operating Leases for Fortress Biotech (FBIO) over the last 7 years, with Q3 2025 value amounting to $12.8 million.

  • Fortress Biotech's Operating Leases fell 1652.5% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year decrease of 1652.5%. This contributed to the annual value of $14.8 million for FY2024, which is 1931.95% down from last year.
  • Latest data reveals that Fortress Biotech reported Operating Leases of $12.8 million as of Q3 2025, which was down 1652.5% from $13.3 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Operating Leases ranged from a high of $23.7 million in Q3 2022 and a low of $12.8 million during Q3 2025
  • For the 5-year period, Fortress Biotech's Operating Leases averaged around $18.8 million, with its median value being $19.5 million (2023).
  • In the last 5 years, Fortress Biotech's Operating Leases soared by 1509.24% in 2023 and then plummeted by 2515.61% in 2024.
  • Over the past 5 years, Fortress Biotech's Operating Leases (Quarter) stood at $21.0 million in 2021, then increased by 2.79% to $21.6 million in 2022, then decreased by 15.25% to $18.3 million in 2023, then fell by 19.32% to $14.8 million in 2024, then fell by 13.46% to $12.8 million in 2025.
  • Its Operating Leases was $12.8 million in Q3 2025, compared to $13.3 million in Q2 2025 and $13.8 million in Q1 2025.